These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 8362234

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR, Huang WK, Shyr JM, Lau YJ, Liu YC, Luh KT.
    J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae.
    Stefani S, Pellegrino MB, D'Amico G, Privitera A, Privitera O, Maccarrone G, Russo G, Nicoletti G.
    Chemotherapy; 1992 Sep; 38(1):36-45. PubMed ID: 1618002
    [Abstract] [Full Text] [Related]

  • 4. Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group.
    Blondeau JM, Suter M, Borsos S.
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():25-30. PubMed ID: 10225568
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q, Xu Y, Chen M, Wang H, Sun H, Hu Y, Zhang R, Duan Q, Zhuo C, Cao B, Liu Y, Yu Y, Sun Z, Chu Y.
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Comparative antibacterial activity of cefpodoxime against Haemophilus influenzae, Streptococcus pyogenes, Streptococcus pneumoniae and Moraxella catarrhalis].
    Wallrauch-Schwarz C, Milatovic D, Braveny I.
    Arzneimittelforschung; 1994 May; 44(5):668-70. PubMed ID: 8024645
    [Abstract] [Full Text] [Related]

  • 12. [Serotype distribution and drug resistance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from nasopharynx of Uygur children].
    Tian HL, Shi W, Zhou HF, Yuan L, Yao KH, Rexiati D, Xu AM.
    Zhonghua Er Ke Za Zhi; 2018 Apr 02; 56(4):279-283. PubMed ID: 29614568
    [Abstract] [Full Text] [Related]

  • 13. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
    Melo-Cristino J, Fernandes ML, Serrano N, Grupo de Estudo Português de Bactérias Patogénicas Respiratórias.
    Acta Med Port; 2001 Apr 02; 14(5-6):459-68. PubMed ID: 11878155
    [Abstract] [Full Text] [Related]

  • 14. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods.
    Morrissey I, Robbins M, Viljoen L, Brown DF.
    J Antimicrob Chemother; 2005 Feb 02; 55(2):200-8. PubMed ID: 15649996
    [Abstract] [Full Text] [Related]

  • 15. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007].
    Sun HL, Yang QW, Xu YC, Wang H, Xie XL, Chen MJ, Zhang XZ, Liu Y, Ye HF, Sun ZY, Duan Q, Ni YX, Yu YS, Zhao WS, He L, Wang J, Ji P, Liu PP, Zhang LX.
    Zhonghua Yi Xue Za Zhi; 2009 Nov 17; 89(42):2983-7. PubMed ID: 20137709
    [Abstract] [Full Text] [Related]

  • 16. Activity of oral antibiotics against respiratory tract pathogens in Spain.
    Calvo A, Amores R, Valero E, Fuentes F, Gómez-Lus ML, Prieto J, Working Group for the Study of Cefpodoxime.
    Rev Esp Quimioter; 2003 Dec 17; 16(4):436-43. PubMed ID: 14961138
    [Abstract] [Full Text] [Related]

  • 17. In vitro evaluation of ceftibuten (7432-S, SCH 39720), a novel orally administered cephalosporin.
    Jones RN, Barry AL.
    Chemioterapia; 1988 Oct 17; 7(5):283-6. PubMed ID: 3147148
    [Abstract] [Full Text] [Related]

  • 18. Sensitivity to sparfloxacin and other antibiotics, of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis strains isolated from adult patients with community-acquired lower respiratory tract infections: a European multicentre study. SPAR Study Group. Surveillance Programme of Antibiotic Resistance.
    Richard MP, Aguado AG, Mattina R, Marre R.
    J Antimicrob Chemother; 1998 Feb 17; 41(2):207-14. PubMed ID: 9533462
    [Abstract] [Full Text] [Related]

  • 19. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
    Koeth LM, Jacobs MR, Good CE, Bajaksouzian S, Windau A, Jakielaszek C, Saunders KA.
    Int J Infect Dis; 2004 Nov 17; 8(6):362-73. PubMed ID: 15494258
    [Abstract] [Full Text] [Related]

  • 20. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014].
    Sun H, Chen L, Chen X, Jia X, Li N, Liu W, Tong H, Xiang R, Zhang F, Zhao H, Zhang J, Xu Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jan 17; 39(1):30-7. PubMed ID: 26792053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.